Member Info for Bladderman

**** sake didn't have time to read the RNS when was 30p as was later for work. Cracking RNS too. Gonads

Let's see a 2.5p plus finish. Then we'll open up tomorrow at 2.6p. 3p plus by the end of the play Friday. Throw in good news or a positive interview and sky's the limit.

Very cashed up now at £10M plus

Start of the re-rate. When above 3p plus you'll feel good about holding down here. Should easily pass that this week. Huge volume and churn today. Brakes are nearly right off

This should easily smash 3p this week...

£25k at full Ask just paid (2.2p).

Brakes are coming off

Over £100k now and full Ask at 2.10p just paid. Derampers ain't going to like it but the market is positive on this stock

Make that £70k - from red to neutral.

Tick tock

Oh dear looks like folk are going to miss out here. Over £50k of buys in the last 25 minutes. Happy days

Pretty awful production rates (50bopd net MSMN) and 15% of Staley is about 10bopd. Mind the helium arm is the value driver here

US patent approval was 2nd June 2021 - yeh real old. Lots more shares sure but lots of more cash in the bank as a consequence. I'd be more worried about buying on a spike at 5-10p. Not any entry at 2p. Anyway let the market decide. All I'm saying is, currently, the SP is a lot closer to the bottom than the top. Each to there own but for £20M it's very good value for money whether you like it or not

Jackodlad...lol.
1-2p what you mean this biotech Pharma should be valued at or just above cash. What about the tech and the collaborations (Eli lilly anf PEN) and the stem cell therapy US patent approval. Oh please. Bore off somewhere else

Buy low and sell high - it's not rocket science. HEMO now has a unique cash position for a £19M company - half cash. Bring on the news flow and interview!

Can see this doing 20-30% one day next week.

At £20M and plenty of cash it's too cheap. The significance of the US stem cell therapy patent approval is only just beginning to filter through

Monday morning could go nuts.

Very undervalued here.

I disagree. The stem cell US patent RNS isnt even priced in yet...

A £50k and £72k buy today tells me this is getting ready to take off

Full Ask getting spanked at 1.95p

We live in a sick world where some individuals think it is cool to make allegations regarding the health of an individual to suit an agenda.

Especially when the individual in question is trying his best to develop significantly less toxic herapies for some very unfortunate individuals that have to deal with such a horrendous diagnosis - what if it were their son or daughter with leukamia or an autoimmune disease.

Shame on them

Is it reasonable to assume we have up to £8M in the bank?

And yet we're sat here at 2p while we churn the last of the Mint.

2p on the Ask now presented

Reversal in play. US patent approval not priced in at all. Look forward to the interview when the market is reminded of what we have here